Terms: = Lymphoma AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Treatment
99 results:
1. Body mass trajectory from diagnosis to the end of treatment in a pediatric acute lymphoblastic leukemia cohort.
Galati PC; Rocha PRS; Gruezo ND; Amato AA
Sci Rep; 2023 Aug; 13(1):13590. PubMed ID: 37604919
[TBL] [Abstract] [Full Text] [Related]
2. First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World Data.
Jeon Y; Park S; Jung HA; Sun JM; Lee SH; Ahn JS; Ahn MJ
Cancer Res Treat; 2024 Jan; 56(1):61-69. PubMed ID: 37448121
[TBL] [Abstract] [Full Text] [Related]
3. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.
Hu YX; Liu Z; Zhang Z; Deng Z; Huang Z; Feng T; Zhou QH; Mei S; Yi C; Zhou Q; Zeng PH; Pei G; Tian S; Tian XF
World J Gastroenterol; 2023 Mar; 29(12):1875-1898. PubMed ID: 37032730
[TBL] [Abstract] [Full Text] [Related]
4. Cardiovascular and Thyroid Late Effects in Pediatric Patients With Hodgkin lymphoma Treated With ABVD Protocol.
Ali N; Selim M; Salah Z; El Nabarawy NM; Hussein H; Sidhom I
J Pediatr Hematol Oncol; 2023 May; 45(4):e455-e463. PubMed ID: 36898022
[TBL] [Abstract] [Full Text] [Related]
5. Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.
Mikulska M; Testi D; Russo C; Balletto E; Sepulcri C; Bussini L; Dentone C; Magne F; Policarpo S; Campoli C; Miselli F; Cilli A; Ghiggi C; Aquino S; Di Grazia C; Giannella M; Giacobbe DR; Vena A; Raiola AM; Bonifazi F; Zinzani P; Cavo M; Lemoli R; Angelucci E; Viale P; Bassetti M; Bartoletti M
Br J Haematol; 2023 May; 201(4):628-639. PubMed ID: 36806152
[TBL] [Abstract] [Full Text] [Related]
6. Measuring what gets done: Using goal attainment scaling in a vocational counseling program for survivors of childhood cancer.
Pole JD; Williams B; Di Giuseppe G; Guger S; Stasiulis E; Greenberg ML; Spiegler BJ; Edelstein K
Cancer Med; 2023 Apr; 12(7):8676-8689. PubMed ID: 36775957
[TBL] [Abstract] [Full Text] [Related]
7. Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and lymphoma.
Demedis J; Scarbro S; Suresh K; Maloney K; Forlenza GP
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e154-e160. PubMed ID: 36715999
[TBL] [Abstract] [Full Text] [Related]
8. Diagnosis and Management of Classical Hodgkin lymphoma During the COVID-19 Pandemic.
Küçükyurt S; Şahin K; Yılmaz U; Erçalışkan A; Özkan Tekin T; Ortaboz D; Elverdi T; Salihoğlu A; Ar MC; Öngören Ş; Başlar Z; Eşkazan AE
Curr Probl Cancer; 2022 Dec; 46(6):100913. PubMed ID: 36399974
[TBL] [Abstract] [Full Text] [Related]
9. Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic lymphoma: Interim Analysis of a Randomized Phase III Trial.
Hillmen P; Eichhorst B; Brown JR; Lamanna N; O'Brien SM; Tam CS; Qiu L; Kazmierczak M; Zhou K; Šimkovič M; Mayer J; Gillespie-Twardy A; Shadman M; Ferrajoli A; Ganly PS; Weinkove R; Grosicki S; Mital A; Robak T; Österborg A; Yimer HA; Salmi T; Ji M; Yecies J; Idoine A; Wu K; Huang J; Jurczak W
J Clin Oncol; 2023 Feb; 41(5):1035-1045. PubMed ID: 36395435
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Effect of Systemic Therapy and Radiation Therapy in Stage I Nodal Marginal Zone lymphoma.
Chevli N; Margolis V; Haque W; Pingali SR; Butler EB; Teh BS
Pract Radiat Oncol; 2023; 13(1):e80-e93. PubMed ID: 36223873
[TBL] [Abstract] [Full Text] [Related]
11. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract] [Full Text] [Related]
12. Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort.
Baldacci S; Besse B; Avrillon V; Mennecier B; Mazieres J; Dubray-Longeras P; Cortot AB; Descourt R; Doubre H; Quantin X; Duruisseaux M; Monnet I; Moro-Sibilot D; Cadranel J; Clément-Duchêne C; Cousin S; Ricordel C; Merle P; Otto J; Schneider S; Langlais A; Morin F; Westeel V; Girard N
Eur J Cancer; 2022 May; 166():51-59. PubMed ID: 35278825
[TBL] [Abstract] [Full Text] [Related]
13. Investigation of the function of the PI3-Kinase / AKT signaling pathway for leukemogenesis and therapy of acute childhood lymphoblastic leukemia (ALL).
Ehm P; Grottke A; Bettin B; Jücker M
Cell Signal; 2022 May; 93():110301. PubMed ID: 35259456
[TBL] [Abstract] [Full Text] [Related]
14. Retrospective literature review of primary neuroendocrine neoplasms of the breast (BNEN) in 209 Chinese patients: treatment and prognostic factor analysis.
Chai Y; Liu M; Li Z; Chen Y; Qi F; Li Q; Xu B
Breast; 2022 Apr; 62():93-102. PubMed ID: 35134665
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods.
Kotrová M; Koopmann J; Trautmann H; Alakel N; Beck J; Nachtkamp K; Steffen B; Raffel S; Viardot A; Wethmar K; Darzentas N; Baldus CD; Gökbuget N; Brüggemann M
Blood Adv; 2022 May; 6(10):3006-3010. PubMed ID: 35026836
[TBL] [Abstract] [Full Text] [Related]
16. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
Enshaei A; Vora A; Harrison CJ; Moppett J; Moorman AV
Lancet Haematol; 2021 Nov; 8(11):e828-e839. PubMed ID: 34715050
[TBL] [Abstract] [Full Text] [Related]
17. Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies.
Sekhri R; Sadjadian P; Becker T; Kolatzki V; Huenerbein K; Meixner R; Marchi H; Wallmann R; Fuchs C; Griesshammer M; Wille K
Ann Hematol; 2021 Nov; 100(11):2707-2716. PubMed ID: 34462786
[TBL] [Abstract] [Full Text] [Related]
18. Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
Kimani S; Painschab MS; Kaimila B; Kasonkanji E; Zuze T; Tomoka T; Mulenga M; Nyasosela R; Chikasema M; Mtangwanika A; Chawinga M; Mhango W; Nicholas S; Chimzimu F; Kampani C; Krysiak R; Lilly A; Randall C; Seguin R; Westmoreland KD; Montgomery ND; Fedoriw Y; Gopal S
Lancet Glob Health; 2021 Jul; 9(7):e1008-e1016. PubMed ID: 34022150
[TBL] [Abstract] [Full Text] [Related]
19. Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.
Balakrishna J; Basumallik N; Matulonis R; Scott D; Salem D; Jasper G; Wiestner A; Stetler-Stevenson M; Marti G; Sun C; Yuan CM
Leuk Lymphoma; 2021 Aug; 62(8):1828-1839. PubMed ID: 33734005
[TBL] [Abstract] [Full Text] [Related]
20. Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent lymphoma.
Fowler NH; Samaniego F; Jurczak W; Ghosh N; Derenzini E; Reeves JA; Knopińska-Posłuszny W; Cheah CY; Phillips T; Lech-Maranda E; Cheson BD; Caimi PF; Grosicki S; Leslie LA; Chavez JC; Fonseca G; Babu S; Hodson DJ; Shao SH; Burke JM; Sharman JP; Law JY; Pagel JM; Miskin HP; Sportelli P; O'Connor OA; Weiss MS; Zinzani PL
J Clin Oncol; 2021 May; 39(15):1609-1618. PubMed ID: 33683917
[TBL] [Abstract] [Full Text] [Related]
[Next]
